Press release
United States Neuropathic Pain Market Share 2025 | Leading Players & Emerging Treatment Paths - Vertex Pharmaceuticals, Abbott, Medtronic, Nevro Corp., Grünenthal
Neuropathic Pain Market
DataM Intelligence has published a new research report on "Neuropathic Pain Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/neuropathic-pain-market?kb
Key Players:
Pfizer Inc., AdvaCare Pharma, Eli Lilly and Company., Vertex Pharmaceuticals, Abbott, Medtronic, Nevro Corp., Grünenthal, Teva Pharmaceuticals Inc., and Sun Pharmaceutical Industries Ltd
Key Development:
In November 2024, Grünenthal announced that its U.S. subsidiary, Averitas Pharma, successfully completed patient enrollment for the Phase III AV001 trial. The study aims to assess the efficacy, safety, and tolerability of the QUTENZA (capsaicin) 8% topical system for post-surgical neuropathic pain (PSNP). Positive outcomes could pave the way for a U.S. label expansion for QUTENZA.
Growth Forecast Projected:
The Global Neuropathic Pain Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Neuropathic Pain Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @: https://www.datamintelligence.com/buy-now-page?report=neuropathic-pain-market?kb
Key Segments:
By Type: Diabetic Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Post-Herpetic Neuralgia, Trigeminal Neuralgia, Spinal Stenosis, Others
By Treatment Type: Drug Class, Anticonvulsants, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Opioids, Capsaicin Cream, Local Anesthetics, Steroids, Others, Devices
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Regional Analysis for Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Neuropathic Pain producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Neuropathic Pain revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/neuropathic-pain-market?kb
FAQ's
Q1: What is the current size of the Neuropathic Pain Market?
A: The Neuropathic Pain Market stood at US$ 8.44 Billion in 2024 and is set to experience remarkable growth, reaching US$ 18.45 Billion by 2033
Q2: How fast is the Neuropathic Pain Market growing?
A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 8.9 % from 2025 to 2032
Get 2-Day Free Trial + 50% OFF DataM Subscription@: https://www.datamintelligence.com/reports-subscription?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Neuropathic Pain Market Share 2025 | Leading Players & Emerging Treatment Paths - Vertex Pharmaceuticals, Abbott, Medtronic, Nevro Corp., Grünenthal here
News-ID: 4282146 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Polymers for 3D Printing Market Accelerates with 19.6% CAGR as PEEK & PEKK Trans …
The global Polymers for 3D Printing Market was valued at US$ 1.17 billion in 2024 and is projected to reach US$ 4.09 billion by 2031, expanding at a strong CAGR of 19.6% during the forecast period. High-performance polymer materials such as PEEK and PEKK also show rapid acceleration, with their segment expected to climb from US$ 1.43 billion in 2024 to US$ 7.14 billion by 2033, reflecting the rising demand…
Automotive Semiconductor Market Expansion: Asia-Pacific's 71.5% Manufacturing Sh …
The U.S. automotive semiconductor market was valued at US$ 8.93 billion in 2023 and is projected to reach US$ 17.05 billion by 2030, growing at a robust CAGR of 9.7% during 2024-2030. With a commanding 27.8% global share, the U.S. stands as one of the most influential hubs for advanced automotive electronics. Rapid adoption of electric vehicles, ADAS technologies, connectivity solutions, and power electronics is significantly boosting semiconductor penetration across…
Geopolymer Market Set to Soar at 29.2% CAGR as Asia-Pacific Commands 45% Global …
Global Geopolymer Market reached USD 9.2 billion in 2022 and is expected to reach USD 71.7 billion by 2031, growing with a CAGR of 29.2% during the forecast period 2024-2031.
The Market Is driven by rising demand for sustainable construction materials, strict emission regulations, and cost-efficient use of industrial waste like fly ash and slag, boosting adoption across infrastructure projects.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/geopolymer-market?pratik…
United States Head and Neck Cancer Pipeline Insights 2025: Clinical Trial Hot Sp …
Head and neck cancer refers to a group of cancers that develop in the tissues and structures of the head and neck, including the mouth, throat, larynx (voice box), sinuses, nasal cavity, salivary glands, and lymph nodes in the neck. These cancers typically arise from the squamous cells that line these areas, known as squamous cell carcinomas, although other types of cancer can occur. Early detection and treatment can lead…
More Releases for Neuropathic
Key Trends Reshaping the Neuropathic Pain Market: Integration Of Artificial Inte …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neuropathic Pain Market Size Growth Forecast: What to Expect by 2025?
The market valuation for neuropathic pain has experienced robust expansion lately, projected to ascend from a figure of $5.35 billion in 2024 to $5.78 billion the following year, reflecting a steady compound annual growth rate (CAGR) of 7.9%;…
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which…
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others.
The Neuropathic Ocular Pain market…
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would…
